11.01.2021
Prevent & Delay
$1,810,735.00
48 months
Linking disease mechanism and clinical trial design via rapidly conducted immunotherapy trials in T1D
Funds support a mechanistic clinical trial into a combination therapy to treat type 1 diabetes (T1D).